Aditya Birla Sun Life Pharma & Healthcare Fund - IDCW - Direct Plan

Other Plans and Options
  • 0.64 %Nav, as on 12-05-2025

  • Previous Nav

  • Net Change on 12-05-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW 3.68 -3.26 13.78 21.14 20.66 21.89
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW Jul 10, 2019 13.78 21.14 20.66 1.06 818.33
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 16.36 22.23 22.90 0.91 8,259.60
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 23.55 26.28 25.85 1.18 5,295.32
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 22.79 27.23 25.69 0.90 3,670.62
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 19.24 21.43 23.56 0.61 2,682.70
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 17.65 23.20 23.25 0.72 1,222.72

Fund Holdings as on 30-April-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • Torrent Pharmaceuticals Limited

  • Abbott India Limited

  • Aurobindo Pharma Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Ajanta Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Ltd

  • J.B. Chemicals & Pharmaceuticals Limited

  • ALEMBIC PHARMACEUTICALS LIMITED

  • GlaxoSmithKline Pharmaceuticals Limited

  • Jupiter Life Line Hospitals Ltd

  • Emcure Pharmaceuticals Ltd

  • SAI Life Sciences Ltd

  • Clearing Corporation of India Limited

  • Medi Assist Healthcare Services Ltd

  • Dr. Reddys Laboratories Limited

  • Sanofi India Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Procter & Gamble Health Limited

  • SANOFI CONSUMER HEALTHCARE

  • Akums Drugs & Pharmaceuticals Ltd

  • Vijaya Diagnostic Centre Limited

  • Suraksha Diagnostic Ltd

  • Vinati Organics Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Chemicals

View More

Most Recent Dividend

  • 24/09/2024

  • 22/09/2023

  • 27/09/2022

  • 28/09/2021

  • 01/10/2020

  • Cash

  • Equity

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹818.33 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.14(0.64%)yesterday to ₹22.09.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111